Taghizade, N. Et Al. 2023. Therapeutic Modalities and Clinical Outcomes in a Large Cohort with LRBA Deficiency and CTLA4 Insufficiency.. The Journal of allergy and clinical immunology , vol.152 , 1634-1645.

Taghizade, N., Babayeva, R., Kara, A., Karakus, I. S., Catak, M. C., Bulutoglu, A., ... Haskologlu, Z. S.(2023). Therapeutic Modalities and Clinical Outcomes in a Large Cohort with LRBA Deficiency and CTLA4 Insufficiency.. The Journal of allergy and clinical immunology , vol.152, 1634-1645.

Taghizade, Nigar Et Al. "Therapeutic Modalities and Clinical Outcomes in a Large Cohort with LRBA Deficiency and CTLA4 Insufficiency.," The Journal of allergy and clinical immunology , vol.152, 1634-1645, 2023

Taghizade, Nigar Et Al. "Therapeutic Modalities and Clinical Outcomes in a Large Cohort with LRBA Deficiency and CTLA4 Insufficiency.." The Journal of allergy and clinical immunology , vol.152, pp.1634-1645, 2023

Taghizade, N. Et Al. (2023) . "Therapeutic Modalities and Clinical Outcomes in a Large Cohort with LRBA Deficiency and CTLA4 Insufficiency.." The Journal of allergy and clinical immunology , vol.152, pp.1634-1645.

@article{article, author={Nigar Taghizade Et Al. }, title={Therapeutic Modalities and Clinical Outcomes in a Large Cohort with LRBA Deficiency and CTLA4 Insufficiency.}, journal={The Journal of allergy and clinical immunology}, year=2023, pages={1634-1645} }